EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity. [electronic resource]
Producer: 20121218Description: 1015-29 p. digitalISSN:- 1744-8301
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Gefitinib
- Germ-Line Mutation
- Humans
- Polymorphism, Genetic
- Protein Kinase Inhibitors -- adverse effects
- Quinazolines -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.